REFERENCES
- Brandt, S.D.; Sumnall, H.R.; Measham, F. & Cole, J. 2010. Second generation mephedrone: The confusing case of NRG-1. British Medical Journal 341: c3564.
- Carhart-Harris, R.L.; King, L.A. & Nutt, D.J. 2011. A web-based survey on mephedrone. Drug and Alcohol Dependence 118: 19–22.
- Corliss, H.L.; Rosario, M.; Wypij, D.; Wylie, S.A.; Frazier, A.L. & Austin, B. 2010. Sexual orientation and drug use in a longitudinal cohort study of U.S. adolescents. Addictive Behaviors 35: 517–521.
- Dahl, J. 2012. Bath salts, drug alleged “face-chewer” Rudy Eugene may have been on, plague police and doctors. CBS News, May 30, 2012. Available at: http://www.cbsnews.com/8301-504083_162-57443712-504083/bath-salts-drug-alleged-face-chewer-rudy-eugene-may-have-been-on-plague-police-and-doctors/
- Dargan, P.I.; Albert, S. & Wood, D.M. 2010. Mephedrone use and associate adverse effects in school and college/university students before the UK legislation change. Quarterly Journal of Medicine 103: 875–879.
- Fass, J.A.; Fass, A.D. & Garcia, A.S. 2012. Synthtic cathinones (bath salts): Legal status and patterns of abuse. Annuals of Pharmacotherapy 46: 436–441.
- Ford, J.A.; Watkins, W.C. & Blumenstein, L. 2011. Correlates of Salvia divinorum use in a national sample: Findings from the 2009 National Survey on Drug Use and Health. Addictive Behaviors 36 (11): 1032–1037.
- Ganim, S. 2011. New products in works to replace banned bath salts, synthetic pot, salvia. The Patriot-News, August 22, 2011. Available at: http://www.pennlive.com/midstate/index.ssf/2011/08/new_products_in_works_to_repla.html
- Georgia Senate. 2011. Controlled Substances; Schedule I, III, IV, V; “dangerous drug”; provisions. Georgia Senate Bill 93.
- Jerry, J.; Collins, G. & Streem, D. 2012. Synthetic legal intoxicating drugs: The emerging “incense” and “bath salt” phenomenon. Cleveland Clinincal Journal of Medicine 79: 258–264.
- Johnston, L.D.; O’Malley, P.M.; Bachman, J.G. & Schulenberg, J.E. 2012. Monitoring the Future National Survey Results on Drug Use, 1975–2011: Volume I, Secondary School Students. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
- Johnston, L.D.; O’Malley, P.M.; Bachman, J.G. & Schulenberg, J.E. 2013. Monitoring the Future National Survey Results on Drug Use, 1975–2012: Volume II, College Students and Adults Ages 19-50. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
- Khey, D.N.; Miller, B.L. & Griffin, O.H. 2008. Salvia divinorum use among a college student sample. Journal of Drug Education 38: 297–306.
- King, G. & Zeng, L. 2001. Logistic regression in rare events data. Political Analysis 9: 137–163.
- Lange, J.E.; Reed, M.B.; Ketchie Croff, J.M. & Clapp, J.D. 2008. College student use of Salvia divinorum. Drug and Alcohol Dependence 94: 263–266.
- McElrath, K. & O’Neill, C. 2011. Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy 22: 120–127.
- Miller, B.L.; Boman, J.H. IV& Stogner, J.M. 2013. Measuring novel drug perceptions: Salvia divinorum, gender, and peer delinquency. Substance Use & Misuse 48 (1–2): 65–72.
- Prosser, J.M. & Nelson, L.S. 2012. The toxicology of bath salts: A review of synthetic cathinones. Journal of Medical Toxicology 8: 33–42.
- Ross, E.A.; Watson, M. & Goldberger, B. 2011. “Bath salts” intoxication. New England Journal of Medicine 365: 967–968.
- Spiller, H.A.; Ryan, M.L.; Weston, R.G. & Jansen, J. 2011. Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clinical Toxicology 49: 499–505.
- Stogner, J.M.; Khey, D.N.; Griffin, O. H. III; Miller, B.L. & Boman, J.H. IV. 2012. Examining the effect of regulating a novel drug: An evaluation of changes in use of Salvia divinorum in the first year of Florida’s ban International Journal of Drug Policy 23 (6): 512–521.
- Wilkins, C.; Girling, M.; Sweetsur, P.; Huckle, T. & Huakau, J. 2006. Legal Party Pill Use in New Zealand: Prevalence of Use, Availability, Health Harms and “Gateway Effects” of Benzylpiperazine (BZP) and Trifluoromethylphenylpiperazine (TFMPP). Auckland: Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University.
- Winstock, A.R.; Marsden, J. & Mitcheson, L. 2010. What should be done about mephedrone? British Medical Journal 340: c1605.
- Winstock, A.; Mitcheson, L. & Marsden, J. 2010. Mephedrone: Still available and twice the price. The Lancet 376 (9752): 1537.
- Winstock, A.R.; Mitcheson, L.R.; Deluca, P.; Davey, Z.; Corazza, O. & Schfano, F. 2010. Mephedron, new kid for the chop? Addiction 106: 154–161.
- Vandrey R.; Dunn, K.E.; Fry, J.A. & Girling, E.R. 2012. A survey study to characterize use of spice products (synthetic cannabinoids). Drug and Alcohol Dependence 120: 238–241.